A multicenter study of mutational profiling of Chinese ALK plus non-small cell lung cancer patients with acquired resistance to crizotinib using next generation sequencing

被引:0
|
作者
Xu, C. [1 ]
Wang, W. [2 ]
Zhuang, W. [3 ]
Song, Z. [2 ]
Zhu, Y. [4 ]
Chen, G. [1 ]
Fang, M. [2 ]
Lv, T. [5 ]
Song, Y. [5 ]
机构
[1] Fujian Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China
[2] Zhejiang Canc Hosp, Chemotherapy, Hangzhou, Zhejiang, Peoples R China
[3] Fujian Canc Hosp, Med Thorac Oncol, Fuzhou, Fujian, Peoples R China
[4] Zhejiang Rongjun Hosp, Thorac Dis Ctr, Jiaxing, Peoples R China
[5] Jinling Hosp, Resp Med, Nanjing, Jiangsu, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1394P
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Frequency and spectrum of primary resistance mechanism in Chinese ALK plus non-small cell lung cancer patients progressing on crizotinib: A multicenter study
    Wang, W-X.
    Xu, C.
    Zhang, Q-X.
    Zhuang, W.
    Song, Z-B.
    Zhu, Y-C.
    Chen, G.
    Fang, M-Y.
    Lv, T-F.
    Song, Y.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1402 - S1402
  • [2] Mutational profiling of Chinese ROS1 positive non-small cell lung cancer patients with required resistant to crizotinib by next generation sequencing.
    Wang, Wen-xian
    Xu, Chunwei
    Fang, Meiyu
    Zhu, You-cai
    Chen, Yan-ping
    Chen, Yu
    Liao, Xing-hui
    Zhuang, Wu
    Lin, Gen
    Chen, Xiao-hui
    Huang, Yun-jian
    Xu, Hai-peng
    Du, Kai-qi
    Guan, Yan-Fang
    Yi, Xin
    Chen, Gang
    Lv, Tangfeng
    Song, Yong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Mutational profiling by next generation sequencing in patients with metastatic non-small cell lung carcinoma
    Deka, H.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S1596 - S1596
  • [4] Potential resistance mechanisms revealed primary resistance to crizotinib in ROS11 non-small cell lung cancer using next generation sequencing: A multicenter study
    Zhang, Q.
    Xu, C.
    Wang, W.
    Zhuang, W.
    Song, Z.
    Zhu, Y.
    Chen, Y.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [5] Mutational Profiling of Non-Small-Cell Lung Cancer Resistant to Osimertinib Using Next-Generation Sequencing in Chinese Patients
    Nie, Keke
    Jiang, Haiping
    Zhang, Chunling
    Geng, Chuanxin
    Xu, Xiajuan
    Zhang, Ling
    Zhang, Hao
    Zhang, Zhongfa
    Lan, Ketao
    Ji, Youxin
    [J]. BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [6] Sequencing of ALK Inhibitors in ALK plus Non-Small Cell Lung Cancer
    Gadgeel, Shirish M.
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (06)
  • [7] Real-world mutational profiling of Chinese non-small cell lung cancer patients with epidermal growth factor receptor (EGFR) uncommon mutations acquired resistant to icotinib using next generation sequencing: A multicenter study.
    Wang, Wen Xian
    Xu, Chunwei
    Lei, Lei
    Zhu, You-cai
    Li, Jinluan
    Chen, Huafei
    Fang, Yong
    Wang, Hong
    Zhuang, Wu
    Fang, Meiyu
    Zhang, Yinbin
    Wang, Liping
    Zhang, Huibao
    Zhou, Ying
    Zheng, Yu
    Hu, Xugang
    Jiang, Weiping
    Chen, Gang
    Lv, Tangfeng
    Song, Yong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Mutational profile of non-small cell lung cancer patients: Use of next-generation sequencing
    Reis, D.
    Marques, C.
    Dias, M.
    Campainha, S.
    Cirnes, L.
    Barroso, A.
    [J]. PULMONOLOGY, 2020, 26 (01): : 50 - +
  • [9] A multicenter study of NRG1 fusions in Chinese non-small cell lung cancer patients and response to afatinib using next generation sequencing
    Li, X.
    Wang, W.
    Xu, C.
    Pu, X.
    Fang, S.
    Cai, X.
    Fang, Y.
    Zhu, Y.
    Wang, H.
    Liang, X.
    Zhuang, W.
    Zhang, Y.
    Wang, L.
    Cai, X.
    Li, J.
    Feng, H.
    Fang, M.
    Chen, G.
    Lv, T.
    Song, Y.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [10] Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non-Small Cell Lung Cancer
    Doebele, Robert C.
    Pilling, Amanda B.
    Aisner, Dara L.
    Kutateladze, Tatiana G.
    Le, Anh T.
    Weickhardt, Andrew J.
    Kondo, Kimi L.
    Linderman, Derek J.
    Heasley, Lynn E.
    Franklin, Wilbur A.
    Varella-Garcia, Marileila
    Camidge, D. Ross
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (05) : 1472 - 1482